- 1(current)
Q. No.Match List I with List II:
Choose the correct answer from the options given below:
1. A-III, B-I, C-II, D-IV
2. A-III, B-IV, C-I, D-II
3. A-II, B-IV, C-I, D-III
4. A-II, B-I, C-IV, D-III
| List I | List II | ||
| A. | \(\alpha-1\) antitrypsin | I. | Cotton bollworm |
| B. | Cry IAb | II. | ADA deficiency |
| C. | Cry IAc | III. | Emphysema |
| D. | Enzyme replacement therapy | IV. | Corn borer |
1. A-III, B-I, C-II, D-IV
2. A-III, B-IV, C-I, D-II
3. A-II, B-IV, C-I, D-III
4. A-II, B-I, C-IV, D-III
Subtopic: Â Intro to Agri Applications |Â Bt Crops |Â Gene Therapy |
 83%
From NCERT
NEET - 2024
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Match List-I with List-II:
Choose the correct answer from the options given below:
1. A-III, B-II, C- IV, D- I
2. A-II, B-I, C- IV, D- III
3. A-IV, B-III, C- I, D- II
4. A-II, B-IV, C- I, D- III
| List-I | List-II | ||
| A. | Genetically engineered Human Insulin | I. | Gene therapy |
| B. | GM Cotton | II. | E.Coli |
| C. | ADA Deficiency | III. | Antigen-antibody interaction |
| D. | ELISA | IV. | Bacillus thuringiensis |
1. A-III, B-II, C- IV, D- I
2. A-II, B-I, C- IV, D- III
3. A-IV, B-III, C- I, D- II
4. A-II, B-IV, C- I, D- III
Subtopic: Â Bt Crops |Â Other GM Crops |Â Med Applications & Humulin |Â Gene Therapy |Â Molecular Diagnosis |
 90%
From NCERT
NEET - 2024
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Match List - I with List - II
Choose the correct answer from the options given below:
| List-I | List-II | ||
| (A) | Gene therapy | (I) | Separation of DNA fragments |
| (B) | RNA interference | (II) | Diagnostic test for AIDS |
| (C) | ELISA | (III) | Cellular defense |
| (D) | Gel Electrophoresis | (IV) | Allows correction of a gene defect |
Choose the correct answer from the options given below:
| Options: | (A) | (B) | (C) | (D) |
| 1. | IV | I | II | III |
| 2. | IV | II | III | I |
| 3. | IV | III | II | I |
| 4. | IV | III | I | II |
Subtopic: Â Interference RNA Tech |Â Med Applications & Humulin |Â Gene Therapy |Â Molecular Diagnosis |
 91%
From NCERT
NEET - 2023
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
| 1. | Genetically engineered lymphocytes are not immortal cells. |
| 2. | Retroviral vector is introduced into these lymphocytes. |
| 3. | Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages |
| 4. | Lymphocytes from patient's blood are grown in culture, outside the body. |
Subtopic: Â Gene Therapy |
 75%
From NCERT
NEET - 2022
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
When gene targeting involving gene amplification is attempted in an individual's tissue to treat disease, it is known as:
| 1. | Molecular diagnosis | 2. | Safety testing |
| 3. | Biopiracy | 4. | Gene therapy |
Subtopic: Â Gene Therapy |
 69%
From NCERT
NEET - 2021
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
The Adenosine deaminase deficiency results into:
| 1. | Digestive disorder | 2. | Addison's disease |
| 3. | Dysfunction of Immune system | 4. | Parkinson's disease |
Subtopic: Â Gene Therapy |
 83%
From NCERT
NEET - 2021
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Match the following columns and select the correct option.
| Column-I | Column-II | ||
| a. | Bt cotton | (i) | Gene therapy |
| b. | Adenosine deaminase deficiency | (ii) | Cellular defense |
| c. | RNAi | (iii) | Detection of HIV infection |
| d. | PCR | (iv) | Bacillus thuringiensis |
| a | b | c | d | |
| 1. | (iii) | (ii) | (i) | (iv) |
| 2. | (ii) | (iii) | (iv) | (i) |
| 3. | (i) | (ii) | (iii) | (iv) |
| 4. | (iv) | (i) | (ii) | (iii) |
Subtopic: Â Bt Crops |Â Interference RNA Tech |Â Gene Therapy |Â Molecular Diagnosis |
 93%
From NCERT
NEET - 2020
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
- 1(current)
Q. No.
© 2025 GoodEd Technologies Pvt. Ltd.